BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6656170)

  • 1. [Plasma separation as an effective treatment of glomerulonephritis in lupus erythematosus].
    Michalk D; Scharf J; Waldherr R
    Klin Padiatr; 1983; 195(6):418-21. PubMed ID: 6656170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
    Sinniah R; Feng PH
    Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis in glomerulonephritis.
    McKenzie PE; Taylor AE; Woodroffe AJ; Seymour AE; Chan YL; Clarkson AR
    Clin Nephrol; 1979 Sep; 12(3):97-108. PubMed ID: 509788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
    Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
    Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
    Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
    Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis in hereditary angioneurotic edema and systemic lupus erythematosus.
    Young DW; Thompson RA; Mackie PH
    Arch Intern Med; 1980 Jan; 140(1):127-8. PubMed ID: 7352788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of idiopathic and systemic lupus erythematosus-associated membranous glomerulonephropathy in children. The Southwest Pediatric Nephrology Study Group.
    Am J Kidney Dis; 1986 Feb; 7(2):115-24. PubMed ID: 3484901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study.
    Clark WF; Lindsay RM; Cattran DC; Chodirker WB; Barnes CC; Linton AL
    Can Med Assoc J; 1981 Jul; 125(2):171-4. PubMed ID: 7272867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The usefulness of plasmapheresis in a case of nephrotic syndrome in Berger's disease].
    Pergolini M; Coppotelli L; Paradiso M; Mammarella A; Boccia P; Leonardo M; Basili S; Pettirossi G; Paoletti V; Cordova C
    Clin Ter; 1996 Nov; 147(11):543-7. PubMed ID: 9264907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
    Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
    Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmapheresis in the treatment of extracapillary glomerulonephritis (author's transl)].
    Sanz Guajardo D; Barbolla ML; Fernández Fernández J; Gallego JL; Anaya A; Botella J
    Med Clin (Barc); 1980 May; 74(9):337-41. PubMed ID: 7382624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus glomerulonephritis in children.
    Garin EH; Shulman ST; Donnelly WH; Richard GA
    Paediatrician; 1981; 10(5-6):351-67. PubMed ID: 6460214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
    Kolesnik NA; Dudar' IA; Velichko MB
    Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.
    Izumi T; Hyodo T; Kikuchi Y; Imakiire T; Ikenoue T; Suzuki S; Yoshizawa N; Miura S
    Am J Kidney Dis; 2005 Oct; 46(4):e59-63. PubMed ID: 16183409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Talwin addict nephropathy.
    Stachura I; Jayakumar S; Pardo M
    Clin Nephrol; 1983 Mar; 19(3):147-53. PubMed ID: 6839565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of an elderly SLE patient associated with acute renal failure].
    Fujita Y; Yuasa S; Yura T; Sumikura T; Takahashi N; Shoji T; Uchida K; Aono M; Fujioka H; Matsuo H
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1201-4. PubMed ID: 8280292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of systemic lupus erythematosus associated with minimal change nephrotic syndrome].
    Horita Y; Nazneen A; Cheng M; Razzaque MS; Namie S; Tadokoro M; Taura K; Miyazaki M; Ozono Y; Kohno S; Harada T; Taguchi T
    Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):759-64. PubMed ID: 9396245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.